{"schema_version":"secwatch.filing_event.v1","accession":"0001447362-21-000166","form_type":"8-K","ticker":"CSTL","cik":"0001447362","company_name":"CASTLE BIOSCIENCES INC","filed_at":"2021-07-16T23:59:59+00:00","discovered_at":"2026-05-14T18:04:18.136184+00:00","generated_at":"2026-06-30T04:47:29.541615+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Castle Biosciences appoints Kimberlee Caple and Ellen Goldberg to board","bullets":["Appointed Kimberlee Caple as Class III director (term until 2022 annual meeting).","Appointed Ellen Goldberg as Class I director (term until 2023 annual meeting).","Each receives $40,000 annual cash, 5,365 stock options, and 1,320 RSUs per standard policy."],"urls":{"canonical":"https://secwatch.observer/filing/0001447362-21-000166","json":"https://secwatch.observer/filing/0001447362-21-000166.json","markdown":"https://secwatch.observer/filing/0001447362-21-000166.md","text":"https://secwatch.observer/filing/0001447362-21-000166.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1447362/000144736221000166/0001447362-21-000166-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1447362/000144736221000166/cstl-20210714.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T04:47:29.541615+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6b981def11","claim":"Kimberlee Caple was appointed as Class III Director at CASTLE BIOSCIENCES INC.","evidence_excerpt":"the Board appointed (i) Kimberlee Caple to serve as a Class III director until the Company’s 2022 annual meeting of stockholders","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736221000166/0001447362-21-000166-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class III Director"}],"fact_type":"executive_change"},{"claim_id":"d5b1a20b77","claim":"Ellen Goldberg was appointed as Class I Director at CASTLE BIOSCIENCES INC.","evidence_excerpt":"and (ii) Ellen Goldberg to serve as a Class I director until the Company’s 2023 annual meeting of stockholders","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736221000166/0001447362-21-000166-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class I Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}